User menu

A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis.

Bibliographic reference Kilani, M ; Micallef, J ; Soubrouillard, C ; Rey-Lardiller, D ; Dematteï, C ; et. al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis.. In: Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, Vol. 5, no. 1, p. 46-54 (2004)
Permanent URL
  2. Przedborski S, Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology, 47, 1546 (1996)
  3. Ince P. G., Lowe J., Shaw P. J., Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology, 10.1046/j.1365-2990.1998.00108.x
  4. Wightman G, Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett, 139, 269 (1992)
  5. Desai J., Swash M., Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion, 10.1136/jnnp.67.2.214
  6. Abrahams S., Leigh P.N., Kew J.J.M., Goldstein L.H., Lloyd C.M.L., Brooks D.J., A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis, 10.1016/0022-510x(95)00060-f
  7. Gallassi R., Montagna P., Ciardulli C., Lorusso S., Mussuto V., Stracciari A., Cognitive impairment in motor neuron disease, 10.1111/j.1600-0404.1985.tb03231.x
  8. Gallassi R, Neuropsychological, elctroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol, 29, 115 (1989)
  9. David Anthony S., Gillham Ruth A., Neuropsychological study of motor neuron disease, 10.1016/s0033-3182(86)72673-x
  10. Ludolph AC, Regard M et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychological and positron emission study. Acta Neurol Scand, 85, 81 (1992)
  11. Kew JJ, The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission study. Brain, 116, 1399 (1993)
  12. Massman P J, Sims J, Cooke N, Haverkamp L J, Appel V, Appel S H, Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis., 10.1136/jnnp.61.5.450
  13. Chari Ganesh, Shaw Pamela J., Sahgal Arjun, Nonverbal visual attention, but not recognition memory or learning, processes are impaired in motor neurone disease, 10.1016/0028-3932(95)00122-0
  14. Abe Kazuo, Fujimura Harutoshi, Toyooka Keiko, Sakoda Saburo, Yorifuji Shiro, Yanagihara Takehiko, Cognitive function in amyotrophic lateral sclerosis, 10.1016/s0022-510x(96)05338-5
  15. Talbot P R, Goulding P J, Lloyd J J, Snowden J S, Neary D, Testa H J, Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study., 10.1136/jnnp.58.5.541
  16. Abrahams S, Leigh P.N, Harvey A, Vythelingum G.N, Grisé D, Goldstein L.H, Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS), 10.1016/s0028-3932(99)00146-3
  17. Abrahams S, Brain, 1996, 2105
  18. Lloyd C. M., Richardson M. P., Brooks D. J., Al-Chalabi A., Leigh P. N., Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil, 10.1093/brain/123.11.2289
  19. Gallagher J. P., Pathologic laughter and crying in ALS: a search for their origin, 10.1111/j.1600-0404.1989.tb03851.x
  20. Tedman B.M, Young C.A, Williams I.R, Assessment of depression in patients with motor neuron disease and other neurologically disabling illness, 10.1016/s0022-510x(97)00249-9
  21. Abrahams S, Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 62, 464 (1997)
  22. NORRIS F. H., CALANCHINI P. R., FALLAT R. J., PANCHARI S., JEWETT B., The administration of guanidine in amyotrophic lateral sclerosis, 10.1212/wnl.24.8.721
  23. Lacomblez L., Bouche P., Bensimon G., Meininger V., A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis, 10.1212/wnl.39.12.1635
  24. Yesavage JA., Psychopharmacol Bull, 24, 709 (1988)
  25. Folstein Marshal F., Folstein Susan E., McHugh Paul R., “Mini-mental state”, 10.1016/0022-3956(75)90026-6
  26. McHugo Gregory J., Smith Craig A., Lanzetta John T., The structure of self-reports of emotional responses to film segments, 10.1007/bf00998191
  27. Philippot Pierre, Inducing and assessing differentiated emotion-feeling states in the laboratory, 10.1080/02699939308409183
  28. Izard CE, The Differential Emotions Scale: a method of measuring the meaning of subjective experience of discrete emotions (1974)
  29. Ouss L, L’Ence´phale, 16, 453 (1990)
  30. Nelson Hazel E., A Modified Card Sorting Test Sensitive to Frontal Lobe Defects, 10.1016/s0010-9452(76)80035-4
  31. Wechsler D., Echelle d’intelligence de Wechsler pour adultes. Forme re´vise´e WAIS-R (1989)
  32. Lezak MD., p. 381 (1995)
  33. Rey A., L’examen clinique en psychologie (1964)
  34. Benton AL. Test de re´tention visuelle. Centre de Psychologie Applique´e, Paris, 1974.
  35. Vieregge P., Wauschkuhn B., Heberlein I., Hagenah J., Verleger R., Selective attention is impaired in amyotrophic lateral sclerosis—a study of event-related EEG potentials, 10.1016/s0926-6410(99)00004-x
  36. Cobble Margaret, Language impairment in motor neurone disease, 10.1016/s0022-510x(98)00198-1
  37. McCullagh Scott, Moore Myrna, Gawel Marek, Feinstein Anthony, Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction, 10.1016/s0022-510x(99)00214-2
  38. Bixler EO, Curr Ther Res Clin Exp, 15, 13 (1973)
  39. Moore MJ, J Neurol Sci, 160, S53 (1999)
  40. Böcker F., Seibold Irmgard, Neundörfer B., Behinderung im Alltag und subjektives Befinden bei Patienten mit fortgeschrittener myatrophischer Lateralsklerose (ALS), 10.1055/s-2007-1001186
  41. Newsom-Davis I.C., Abrahams S., Goldstein L.H., Leigh P.N., The emotional lability questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis, 10.1016/s0022-510x(99)00211-7
  42. Wozniak D. F., Olney J. W., Kettinger L., Price M., Miller J. P., Behavioral effects of MK-801 in the rat, 10.1007/bf02253717
  43. Brosnan-Watters G., Wozniak D.F., Nardi A., Olney J.W., Acute behavioral effects of MK-801 in the mouse, 10.1016/0091-3057(95)02073-x
  44. Oye I, J Pharmacol Exp Therap, 260, 1209 (1992)
  45. Saletu Grunberger J, I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Meth Find Exp Clin Pharmacol, 18, 55 (1996)
  46. Stefan Katja, Kunesch Erwin, Benecke Reiner, Classen Joseph, Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis, 10.1002/ana.107
  47. Lomen-Hoerth C., Murphy J., Langmore S., Kramer J. H., Olney R. K., Miller B., Are amyotrophic lateral sclerosis patients cognitively normal?, 10.1212/01.wnl.0000055861.95202.8d
  48. Strong M. J., Grace G. M., Orange J. B., Leeper H. A., Menon R. S., Aere C., A prospective study of cognitive impairment in ALS, 10.1212/wnl.53.8.1665